Clinical Trials Browser

Phase 2 × Carcinoma, Basal Cell × cemiplimab × Clear all

NCT06981325 2026-03-11

CEMI-first

Phase 2 Recruiting

Carcinoma, Basal Cell, Skin Neoplasms

NCT03132636 2025-04-08

PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy

Phase 2 Completed

138 enrolled 21 charts 1 FDA

Carcinoma, Basal Cell